A recent review identifies interleukin-36 (IL-36) as a transformative driver of vascular inflammation, revealing that serum ...

A new discovery from UC San Diego researchers could enable easier treatment of high-grade serous ovarian cancer, the most common and aggressive form of ovarian cancer.

High-grade serous ovarian cancer is the most common and aggressive form of ovarian cancer and often becomes resistant to ...

Explore new findings on ovarian cancer and how blocking focal adhesion kinase can enhance immune response in treatment.